Kostas D. Odysseas - Jun 7, 2021 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director
Signature
/s/Todd R. Patrick, attorney-in-fact
Stock symbol
ARMP
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 04:25 PM
Previous filing
May 20, 2021
Next filing
Apr 15, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Option (Right to Buy) Award $0 +28K $0.00 28K Jun 7, 2021 Common Stock 28K $4.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant.